Meridia Risk Management Program Strengthened
This article was originally published in The Pink Sheet Daily
Executive Summary
New patient leaflet and revised labeling highlights the risk profile of Abbott's obesity drug. The risk of a "large increase in blood pressure or heart rate" is "the most important information you should know about Meridia," leaflet says. Thirty-count bottles also approved.